Not all SCN1A epileptic encephalopathies are Dravet syndrome

Lynette G. Sadleir, Emily I. Mountier, Deepak Gill, Suzanne Davis, Charuta Joshi, Catherine Devile, Manju A. Kurian, Simone Mandelstam, Elaine C Wirrell, Katherine C Nickels, Hema R. Murali, Gemma Carvill, Candace T. Myers, Heather C. Mefford, Ingrid E. Scheffer

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

To define a distinct SCN1A developmental and epileptic encephalopathy with early onset, profound impairment, and movement disorder. Methods: A case series of 9 children were identified with a profound developmental and epileptic encephalopathy and SCN1A mutation. Results: We identified 9 children 3 to 12 years of age; 7 were male. Seizure onset was at 6 to 12 weeks with hemiclonic seizures, bilateral tonic-clonic seizures, or spasms. All children had profound developmental impairment and were nonverbal and nonambulatory, and 7 of 9 required a gastrostomy. A hyperkinetic movement disorder occurred in all and was characterized by dystonia and choreoathetosis with prominent oral dyskinesia and onset from 2 to 20 months of age. Eight had a recurrent missense SCN1A mutation, p.Thr226Met. The remaining child had the missense mutation p.Pro1345Ser. The mutation arose de novo in 8 of 9; for the remaining case, the mother was negative and the father was unavailable. Conclusions: Here, we present a phenotype-genotype correlation for SCN1A. We describe a distinct SCN1A phenotype, early infantile SCN1A encephalopathy, which is readily distinguishable from the well-recognized entities of Dravet syndrome and genetic epilepsy with febrile seizures plus. This disorder has an earlier age at onset, profound developmental impairment, and a distinctive hyperkinetic movement disorder, setting it apart from Dravet syndrome. Remarkably, 8 of 9 children had the recurrent missense mutation p.Thr226Met.

Original languageEnglish (US)
Pages (from-to)1035-1042
Number of pages8
JournalNeurology
Volume89
Issue number10
DOIs
StatePublished - Sep 5 2017
Externally publishedYes

Fingerprint

Myoclonic Epilepsy
Brain Diseases
Movement Disorders
Missense Mutation
Hyperkinesis
Seizures
Febrile Seizures
Mutation
Gastrostomy
Dystonia
Spasm
Genetic Association Studies
Age of Onset
Fathers
Epilepsy
Mothers
Phenotype

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Sadleir, L. G., Mountier, E. I., Gill, D., Davis, S., Joshi, C., Devile, C., ... Scheffer, I. E. (2017). Not all SCN1A epileptic encephalopathies are Dravet syndrome. Neurology, 89(10), 1035-1042. https://doi.org/10.1212/WNL.0000000000004331

Not all SCN1A epileptic encephalopathies are Dravet syndrome. / Sadleir, Lynette G.; Mountier, Emily I.; Gill, Deepak; Davis, Suzanne; Joshi, Charuta; Devile, Catherine; Kurian, Manju A.; Mandelstam, Simone; Wirrell, Elaine C; Nickels, Katherine C; Murali, Hema R.; Carvill, Gemma; Myers, Candace T.; Mefford, Heather C.; Scheffer, Ingrid E.

In: Neurology, Vol. 89, No. 10, 05.09.2017, p. 1035-1042.

Research output: Contribution to journalArticle

Sadleir, LG, Mountier, EI, Gill, D, Davis, S, Joshi, C, Devile, C, Kurian, MA, Mandelstam, S, Wirrell, EC, Nickels, KC, Murali, HR, Carvill, G, Myers, CT, Mefford, HC & Scheffer, IE 2017, 'Not all SCN1A epileptic encephalopathies are Dravet syndrome', Neurology, vol. 89, no. 10, pp. 1035-1042. https://doi.org/10.1212/WNL.0000000000004331
Sadleir LG, Mountier EI, Gill D, Davis S, Joshi C, Devile C et al. Not all SCN1A epileptic encephalopathies are Dravet syndrome. Neurology. 2017 Sep 5;89(10):1035-1042. https://doi.org/10.1212/WNL.0000000000004331
Sadleir, Lynette G. ; Mountier, Emily I. ; Gill, Deepak ; Davis, Suzanne ; Joshi, Charuta ; Devile, Catherine ; Kurian, Manju A. ; Mandelstam, Simone ; Wirrell, Elaine C ; Nickels, Katherine C ; Murali, Hema R. ; Carvill, Gemma ; Myers, Candace T. ; Mefford, Heather C. ; Scheffer, Ingrid E. / Not all SCN1A epileptic encephalopathies are Dravet syndrome. In: Neurology. 2017 ; Vol. 89, No. 10. pp. 1035-1042.
@article{8b2e0744d86244d68327e3f35f971f7b,
title = "Not all SCN1A epileptic encephalopathies are Dravet syndrome",
abstract = "To define a distinct SCN1A developmental and epileptic encephalopathy with early onset, profound impairment, and movement disorder. Methods: A case series of 9 children were identified with a profound developmental and epileptic encephalopathy and SCN1A mutation. Results: We identified 9 children 3 to 12 years of age; 7 were male. Seizure onset was at 6 to 12 weeks with hemiclonic seizures, bilateral tonic-clonic seizures, or spasms. All children had profound developmental impairment and were nonverbal and nonambulatory, and 7 of 9 required a gastrostomy. A hyperkinetic movement disorder occurred in all and was characterized by dystonia and choreoathetosis with prominent oral dyskinesia and onset from 2 to 20 months of age. Eight had a recurrent missense SCN1A mutation, p.Thr226Met. The remaining child had the missense mutation p.Pro1345Ser. The mutation arose de novo in 8 of 9; for the remaining case, the mother was negative and the father was unavailable. Conclusions: Here, we present a phenotype-genotype correlation for SCN1A. We describe a distinct SCN1A phenotype, early infantile SCN1A encephalopathy, which is readily distinguishable from the well-recognized entities of Dravet syndrome and genetic epilepsy with febrile seizures plus. This disorder has an earlier age at onset, profound developmental impairment, and a distinctive hyperkinetic movement disorder, setting it apart from Dravet syndrome. Remarkably, 8 of 9 children had the recurrent missense mutation p.Thr226Met.",
author = "Sadleir, {Lynette G.} and Mountier, {Emily I.} and Deepak Gill and Suzanne Davis and Charuta Joshi and Catherine Devile and Kurian, {Manju A.} and Simone Mandelstam and Wirrell, {Elaine C} and Nickels, {Katherine C} and Murali, {Hema R.} and Gemma Carvill and Myers, {Candace T.} and Mefford, {Heather C.} and Scheffer, {Ingrid E.}",
year = "2017",
month = "9",
day = "5",
doi = "10.1212/WNL.0000000000004331",
language = "English (US)",
volume = "89",
pages = "1035--1042",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Not all SCN1A epileptic encephalopathies are Dravet syndrome

AU - Sadleir, Lynette G.

AU - Mountier, Emily I.

AU - Gill, Deepak

AU - Davis, Suzanne

AU - Joshi, Charuta

AU - Devile, Catherine

AU - Kurian, Manju A.

AU - Mandelstam, Simone

AU - Wirrell, Elaine C

AU - Nickels, Katherine C

AU - Murali, Hema R.

AU - Carvill, Gemma

AU - Myers, Candace T.

AU - Mefford, Heather C.

AU - Scheffer, Ingrid E.

PY - 2017/9/5

Y1 - 2017/9/5

N2 - To define a distinct SCN1A developmental and epileptic encephalopathy with early onset, profound impairment, and movement disorder. Methods: A case series of 9 children were identified with a profound developmental and epileptic encephalopathy and SCN1A mutation. Results: We identified 9 children 3 to 12 years of age; 7 were male. Seizure onset was at 6 to 12 weeks with hemiclonic seizures, bilateral tonic-clonic seizures, or spasms. All children had profound developmental impairment and were nonverbal and nonambulatory, and 7 of 9 required a gastrostomy. A hyperkinetic movement disorder occurred in all and was characterized by dystonia and choreoathetosis with prominent oral dyskinesia and onset from 2 to 20 months of age. Eight had a recurrent missense SCN1A mutation, p.Thr226Met. The remaining child had the missense mutation p.Pro1345Ser. The mutation arose de novo in 8 of 9; for the remaining case, the mother was negative and the father was unavailable. Conclusions: Here, we present a phenotype-genotype correlation for SCN1A. We describe a distinct SCN1A phenotype, early infantile SCN1A encephalopathy, which is readily distinguishable from the well-recognized entities of Dravet syndrome and genetic epilepsy with febrile seizures plus. This disorder has an earlier age at onset, profound developmental impairment, and a distinctive hyperkinetic movement disorder, setting it apart from Dravet syndrome. Remarkably, 8 of 9 children had the recurrent missense mutation p.Thr226Met.

AB - To define a distinct SCN1A developmental and epileptic encephalopathy with early onset, profound impairment, and movement disorder. Methods: A case series of 9 children were identified with a profound developmental and epileptic encephalopathy and SCN1A mutation. Results: We identified 9 children 3 to 12 years of age; 7 were male. Seizure onset was at 6 to 12 weeks with hemiclonic seizures, bilateral tonic-clonic seizures, or spasms. All children had profound developmental impairment and were nonverbal and nonambulatory, and 7 of 9 required a gastrostomy. A hyperkinetic movement disorder occurred in all and was characterized by dystonia and choreoathetosis with prominent oral dyskinesia and onset from 2 to 20 months of age. Eight had a recurrent missense SCN1A mutation, p.Thr226Met. The remaining child had the missense mutation p.Pro1345Ser. The mutation arose de novo in 8 of 9; for the remaining case, the mother was negative and the father was unavailable. Conclusions: Here, we present a phenotype-genotype correlation for SCN1A. We describe a distinct SCN1A phenotype, early infantile SCN1A encephalopathy, which is readily distinguishable from the well-recognized entities of Dravet syndrome and genetic epilepsy with febrile seizures plus. This disorder has an earlier age at onset, profound developmental impairment, and a distinctive hyperkinetic movement disorder, setting it apart from Dravet syndrome. Remarkably, 8 of 9 children had the recurrent missense mutation p.Thr226Met.

UR - http://www.scopus.com/inward/record.url?scp=85028821137&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028821137&partnerID=8YFLogxK

U2 - 10.1212/WNL.0000000000004331

DO - 10.1212/WNL.0000000000004331

M3 - Article

C2 - 28794249

AN - SCOPUS:85028821137

VL - 89

SP - 1035

EP - 1042

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 10

ER -